|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | American Medical Systems Holdings Inc.(NASDAQ:AMMD ), a global leader in providing pelvic health solutions to urologists. |
|---|---|
| Transferring Party | Laserscope (NASDAQ:LSCP), a manufacturer of minimally invasive laser-based urology devices to treat obstructive benign prostatic hyperplasia (BPH). |
| Sector | Medical Devices |
| Date | June 5, 2006 |
| Analysis Strengthens AMS' strong reputation in urological products with a range of therapy solutions for BPH patients. The use of laser-based technologies for BPH procedures has been rapidly adopted due to physician and patient preference for improved post-procedure outcomes. Global reach of the combined AMS/Laserscope sales force will be positioned to capitalize on Laserscope's technology and market position, while driving operating efficiencies and cost synergies. Deal price is $715m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |